Reinovax PCV24 formulation 1

BIOLOGICAL2 trials

Sponsors

Shanghai Reinovax Biologics Co.,LTD

Conditions

Pneumococcal Infectious Disease

Phase 1

Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older

CompletedNCT06678607

Shanghai Reinovax Biologics Co.,LTDPneumococcal Infectious Disease

Start: 2023-11-19End: 2024-07-28Updated: 2024-11-07

Phase 2

Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Active, not recruitingNCT06678620

Shanghai Reinovax Biologics Co.,LTDPneumococcal Infectious Disease

Start: 2024-04-20End: 2026-03-31Target: 992Updated: 2025-12-17